This meta-analysis confirms that LA is a feasible and safe anticoagulation strategy in patients supported by ECMO. Future studies should focus on the long-term benefits of LA compared with SA.
Evidence that bone-marrow stem-cell transplantation could regenerate damaged cells in the heart after myocardial infarction is demonstrated by separate research among teams […]
